세계의 단백질 어세이 시장 보고서(2025년)
Protein Assays Global Market Report 2025
상품코드 : 1824548
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,482,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,370,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,257,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

단백질 어세이 시장 규모는 향후 몇 년 동안 급성장할 것으로 예상됩니다. 2029년에는 CAGR 14.8%로 57억 달러로 성장할 것입니다. 예측 기간의 성장은 임상 진단에서의 사용 확대, 바이오마커 탐색에 대한 관심 증가, 바이오의약품 생산 및 품질 관리, 연구 플랫폼에서의 기술 통합, 맞춤형 치료를 위한 단백질체학 프로파일링의 증가에 기인합니다. 예측 기간의 주요 동향으로는 신약개발에서 단백질체학 활용 증가, 고감도 분석키트 개발, 표준화 및 분석의 재현성 강조, 단백질체학 데이터와 다른 오믹스 데이터의 통합, 임상 진단에서 단백질 어세이의 확대 등을 들 수 있습니다.

향후 5년간 14.8%의 성장률 전망은 지난번 전망치보다 0.2% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 관세 부과는 스웨덴과 싱가포르에서 수입되는 고정밀 효소 결합 면역 흡착 측정 키트와 질량 분석 표준 시료에 대한 접근을 제한함으로써 미국 실험실에 어려움을 초래할 수 있으며, 바이오마커 연구를 저해하고 연구 개발 예산을 증가시킬 수 있습니다. 또한, 상호 관세와 무역 마찰 및 제한 강화로 인한 세계 경제 및 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.

제약 산업의 확장은 향후 몇 년 동안 단백질 어세이 시장을 촉진할 것으로 예상됩니다. 이 부문은 질병의 예방, 진단, 치료를 목적으로 하는 의약품 및 약품의 연구개발, 제조, 유통에 중점을 두고 있습니다. 제약 산업의 성장에는 세계 건강 수요 증가, 의료비 지출 증가, 예방의학에 대한 관심 증가 등 여러 요인이 기여하고 있습니다. 단백질 어세이는 신약개발, 개발, 품질 관리에 필수적인 단백질의 농도와 활성을 정확하게 측정함으로써 이 산업에서 중요한 역할을 담당하고 있습니다. 예를 들어, 2024년 8월 캐나다 정부가 발표한 데이터에 따르면, 의약품 무역의 국내 수출액은 2021년 107억 1,000만 캐나다 달러에서 2022년 127억 9,000만 캐나다 달러로 증가하고, 수입액은 같은 기간 266억 3,000만 캐나다 달러에서 302억 1,000만 캐나다 달러로 증가할 것으로 예상했습니다. 캐나다 달러로 증가했습니다. 이러한 수출과 수입의 성장은 의약품 무역 부문의 확장을 강조하고 있습니다. 이처럼 제약 산업의 성장이 단백질 어세이 시장을 발전시키고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병

제34장 최근의 시장 동향

제35장 시장 잠재력이 높은 국가, 전략

제36장 부록

KSM
영문 목차

영문목차

Protein assay refers to the process of determining how much or how many distinct proteins there are in a sample, depending on the case. Many clinical and research procedures include the isolation and detection of proteins. The protein assay is used to quantify the presence of a particular protein, or a variety of proteins, in a sample.

Protein assays encompass two primary product types reagents and kits, and instruments. Reagents, substances chosen for their chemical or biological action, are utilized in manufacturing, image development, or component detection. Protein assays employ various technologies, including absorbance-based, colorimetric, and fluorescence-based methods. These assays find applications in diverse industries such as pharmaceuticals, biotechnology, clinical laboratories, hospitals, and academic research institutes.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The protein assays market research report is one of a series of new reports from The Business Research Company that provides protein assays market statistics, including protein assays industry global market size, regional shares, competitors with a protein assays market share, detailed protein assays market segments, market trends and opportunities, and any further data you may need to thrive in the protein assays industry. This protein assays market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The protein assays market size has grown rapidly in recent years. It will grow from $2.9 billion in 2024 to $3.28 billion in 2025 at a compound annual growth rate (CAGR) of 13.3%. The growth in the historic period can be attributed to advancements in proteomic research, drug discovery and development activities, biotechnology and life sciences research, rising prevalence of chronic diseases, increasing adoption of personalized medicine.

The protein assays market size is expected to see rapid growth in the next few years. It will grow to $5.7 billion in 2029 at a compound annual growth rate (CAGR) of 14.8%. The growth in the forecast period can be attributed to expanding applications in clinical diagnostics, growing emphasis on biomarker discovery, biopharmaceutical production and quality control, technological integration in research platforms, rise in proteomic profiling for personalized therapies. Major trends in the forecast period include increased use of proteomics in drug discovery, development of high-sensitivity assay kits, focus on standardization and assay reproducibility, integration of proteomic data with other omics data, expansion of protein assays in clinical diagnostics.

The forecast of 14.8% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may pose challenges for U.S. research labs by restricting access to high-precision Enzyme-Linked Immunosorbent Assay kits and mass spectrometry standards imported from Sweden and Singapore, potentially compromising biomarker studies and increasing Research and Development budgets. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The expansion of the pharmaceutical industry is anticipated to propel the protein assay market in the coming years. This sector focuses on the research, development, manufacturing, and distribution of drugs and medications aimed at preventing, diagnosing, and treating diseases. Several factors contribute to the growth of the pharmaceutical industry, including rising global health demands, increased healthcare spending, and a growing emphasis on preventive care. Protein assays play a crucial role in this industry by providing accurate measurements of protein concentration and activity, essential for drug discovery, development, and quality control. For example, in August 2024, data from the Government of Canada indicated that domestic exports in the pharmaceutical trade rose from 10.71 billion CAD in 2021 to 12.79 billion CAD in 2022, while imports increased from 26.63 billion CAD to 30.21 billion CAD during the same period. This growth in both exports and imports highlights the expanding pharmaceutical trade sector. Thus, the growth of the pharmaceutical industry is driving the protein assay market forward.

The increasing prevalence of chronic diseases is another factor propelling the growth of the protein assay market. Chronic diseases, characterized by lasting a year or longer and requiring continuous medical care, are on the rise. Conditions such as cancer and neurodegenerative disorders are driving the demand for protein assays, which are crucial for biomarker identification and understanding diseases. As projected by the National Center for Biotechnology Information (NCBI) in January 2023, the number of individuals aged 50 years and older with at least one chronic illness is expected to increase by 99.5%, reaching 142.66 million by 2050, up from 71.522 million in 2020. Consequently, the increasing prevalence of chronic diseases contributes significantly to the growth of the protein assay market.

Major players in the protein assay market are directing their efforts towards the creation of innovative solutions, such as 3D spatial analysis kits. These kits, encompassing tools, software, and resources, are tailored for the examination and visualization of spatial data in three dimensions. For instance, in June 2023, Pixelgen Technologies AB, a biotechnology company based in Sweden, introduced the 'Pixelgen Single Cell Spatial Proteomics Kit.' Grounded in MPX technology, this kit has the potential to significantly enhance the understanding of cellular activity. It aims to drive advancements in scientific knowledge, expedite drug discovery and development processes, and enhance diagnostic capabilities. The initial release of the Pixelgen SCSP Kit includes 76 protein assays and 4 controls for simultaneous testing.

Leading companies in the protein assay sector are channeling their focus into the development of innovative solutions, such as high-plex proteomics platforms. These platforms, constituting proteomic technologies or systems, enable the simultaneous analysis of a high number of proteins in a single experiment. For instance, in November 2023, SomaLogic Inc., a US-based proteomics technology company, launched the 'somaScan 11K Platform.' This platform provides 11,000 total protein measurements, offering researchers a significant advantage in uncovering biomarkers and identifying potential drug targets for translational medicine. The addition of 3,500 proteins to the 11K assay is anticipated to reveal new biomarkers previously beyond measurement, potentially contributing to the development of diagnostics with heightened accuracy.

In October 2023, Thermo Fisher Scientific Inc., a biotechnology company based in the US, completed the acquisition of Olink Holding for $3.1 billion. This acquisition is intended to bolster Thermo Fisher Scientific Inc.'s capabilities in protein analysis and biomarker discovery, thereby expanding its range of tools and services for both research and clinical applications. Olink Holding, headquartered in Sweden, is a biotechnology firm that focuses on the discovery and development of protein biomarkers.

Major companies operating in the protein assays market include F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Roche Diagnostics International AG, Danaher Corporation, Merck KGaA, Siemens Healthineers AG, R&D Systems Inc., Lonza Group AG, PerkinElmer Inc., Bio-Rad Laboratories Inc., Takara Bio Inc., Qiagen N.V., Promega Corporation, Abcam plc, Cell Signaling Technology Inc., BioVision Inc., Cayman Chemical Company, Enzo Life Sciences Inc., Novus Biologicals LLC, Abnova Corporation, Elabscience Biotechnology Co Ltd., Geno Technology Inc., Cytoskeleton Inc.

North America was the largest region in the protein assays market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global protein assays market report during the forecast period. The regions covered in the protein assays market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the protein assays market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The protein assay services market includes revenues earned by entities by providing different protein quantitation methods such as enzyme-linked immunosorbent assay (ELISA), western blot analysis, and more recently, mass spectrometry, among others. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Protein Assays Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on protein assays market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for protein assays ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The protein assays market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Protein Assays Market Characteristics

3. Protein Assays Market Trends And Strategies

4. Protein Assays Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Protein Assays Growth Analysis And Strategic Analysis Framework

6. Protein Assays Market Segmentation

7. Protein Assays Market Regional And Country Analysis

8. Asia-Pacific Protein Assays Market

9. China Protein Assays Market

10. India Protein Assays Market

11. Japan Protein Assays Market

12. Australia Protein Assays Market

13. Indonesia Protein Assays Market

14. South Korea Protein Assays Market

15. Western Europe Protein Assays Market

16. UK Protein Assays Market

17. Germany Protein Assays Market

18. France Protein Assays Market

19. Italy Protein Assays Market

20. Spain Protein Assays Market

21. Eastern Europe Protein Assays Market

22. Russia Protein Assays Market

23. North America Protein Assays Market

24. USA Protein Assays Market

25. Canada Protein Assays Market

26. South America Protein Assays Market

27. Brazil Protein Assays Market

28. Middle East Protein Assays Market

29. Africa Protein Assays Market

30. Protein Assays Market Competitive Landscape And Company Profiles

31. Protein Assays Market Other Major And Innovative Companies

32. Global Protein Assays Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Protein Assays Market

34. Recent Developments In The Protein Assays Market

35. Protein Assays Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기